Connect your AI

Opko Health OPK Operating Cash Flow

Operating Cash Flow at other companies

Quest DiagnosticsDGX

$278M-11.5%

Olema Pharmaceuticals, Inc.OLMA

-$45.99M-4.6%

HRO

HarrowHROW

-$8.99M-146%

PrecigenPGEN

-$43.83M-168%

ImmunomeIMNM

-$58.64M-10.5%

Ultragenyx PharmaceuticalRARE

-$197M-18.7%

Other financials

Income statement

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

Market cap$1.13B+10.0%

P/S1.9×+0.5×

Profitability

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opko Health's operating cash flow?: Opko Health (OPK) reported operating cash flow of -$19.31M in Q1 2026.
How has Opko Health's operating cash flow changed year-over-year?: Opko Health's operating cash flow increased by 44.1% year-over-year, from -$34.55M to -$19.31M.
What is the long-term trend for Opko Health's operating cash flow?: Over 3 years (2022 to 2025), Opko Health's operating cash flow has grown at a 23.3% compound annual growth rate (CAGR), from -$95.19M to -$178.54M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.